PHOSPHOLIPID REGULATION OF A CYCLIC AMP-SPECIFIC PHOSPHODIESTERASE (PDE4) FROM U937 CELLS

被引:6
|
作者
DISANTO, ME [1 ]
GLASER, KB [1 ]
HEASLIP, RJ [1 ]
机构
[1] WYETH AYERST RES, DIV INFECT DIS, PRINCETON, NJ 08543 USA
关键词
PHOSPHODIESTERASE; PHOSPHOLIPID; PHOSPHATIDIC ACID; PHOSPHATIDYLSERINE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; LYSOPHOSPHATIDIC ACID;
D O I
10.1016/0898-6568(95)02010-1
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The regulation of phosphodiesterase-4 (PDE4) by various phospholipids was explored using PDE4s partially purified from U937 cells. Preincubation (5 min, 4 degrees C) of the large molecular weight PDE4 denoted ''Peak 2 PDE4'' with mixed phosphatidic acids (PAs) produced a 2-fold increase in its V-max without changing its K-m (similar to 2 mu M) for cyclic AMP. This ''activation'' was not limited to PAs with specific fatty acid substituents: Synthetic PAs containing saturated and/or unsaturated fatty acids 16-20 carbons long produced similar effects. Lysophosphatidic acids (LPAs) and phosphatidylserines (PSs) also induced PDE4 activation, whereas phosphatidylcholines (PCs), phosphatidylethanolamines (PEs) and diacylglycerol did not. Antibodies to a peptide region near the PDE4 catalytic site specifically inhibited PA-induced activation. The data demonstrate that anionic phospholipids can act as non-essential activators of a leukocyte PDE4, and suggest biochemical crosstalk between phospholipid-dependent and cyclic AMP-dependent signalling pathways in human leukocytes.
引用
收藏
页码:827 / 835
页数:9
相关论文
共 50 条
  • [1] Intracellular compartmentalization of PDE4 cyclic AMP-specific phosphodiesterases
    Scotland, G
    Beard, M
    Erdogan, S
    Huston, E
    McCallum, F
    MacKenzie, SJ
    Peden, AH
    Pooley, L
    Rena, NG
    Ross, AH
    Yarwood, SJ
    Houslay, MD
    METHODS-A COMPANION TO METHODS IN ENZYMOLOGY, 1998, 14 (01): : 65 - 79
  • [2] Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling
    Conti, M
    Richter, W
    Mehats, C
    Livera, G
    Park, JY
    Jin, C
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (08) : 5493 - 5496
  • [3] YCLIC AMP-SPECIFIC PHOSPHODIESTERASE-4 PDE4: A NOVEL TARGET FOR ALCOHOL DEPENDENCE
    Hu, W.
    Wen, R. T.
    Huang, Y.
    Hansen, R.
    Wang, C.
    Conti, M.
    Grahame, N.
    Liang, J. H.
    Zhang, H. T.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2011, 35 (06) : 182A - 182A
  • [4] Regulation of cyclic AMP in rat pulmonary microvascular endothelial cells by rolipram-sensitive cyclic AMP phosphodiesterase (PDE4)
    Thompson, WJ
    Ashikaga, T
    Kelly, JJ
    Liu, L
    Zhu, B
    Vemavarapu, L
    Strada, SJ
    BIOCHEMICAL PHARMACOLOGY, 2002, 63 (04) : 797 - 807
  • [5] REGULATION OF DISTINCT CYCLIC AMP-SPECIFIC PHOSPHODIESTERASE (PHOSPHODIESTERASE TYPE-4) ISOZYMES IN HUMAN MONOCYTIC CELLS
    VERGHESE, MW
    MCCONNELL, RT
    LENHARD, JM
    HAMACHER, L
    JIN, SLC
    MOLECULAR PHARMACOLOGY, 1995, 47 (06) : 1164 - 1171
  • [6] Rapid regulation of a cyclic AMP-specific phosphodiesterase (PDE IV) by forskolin and isoproterenol in LRM55 astroglial cells
    Madelian, V
    LaVigne, E
    BIOCHEMICAL PHARMACOLOGY, 1996, 51 (12) : 1739 - 1747
  • [7] Genistein directly inhibits cyclic-AMP specific phosphodiesterase (PDE4) activity
    Nichols, MR
    Morimoto, BH
    FASEB JOURNAL, 1998, 12 (08): : A1483 - A1483
  • [8] Remodelling of the PDE4 cAMP phosphodiesterase isoform profile upon monocyte-macrophage differentiation of human U937 cells
    Shepherd, MC
    Baillie, GS
    Stirling, DI
    Houslay, MD
    BRITISH JOURNAL OF PHARMACOLOGY, 2004, 142 (02) : 339 - 351
  • [9] STIMULATION OF BETA-ADRENOCEPTORS IN A HUMAN MONOCYTE CELL-LINE (U937) UP-REGULATES CYCLIC AMP-SPECIFIC PHOSPHODIESTERASE ACTIVITY
    TORPHY, TJ
    ZHOU, HL
    CIESLINSKI, LB
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1992, 263 (03): : 1195 - 1205
  • [10] ACTIVATION AND SELECTIVE-INHIBITION OF A CYCLIC AMP-SPECIFIC PHOSPHODIESTERASE, PDE-4D3
    ALVAREZ, R
    SETTE, C
    YANG, D
    EGLEN, RM
    WILHELM, R
    SHELTON, ER
    CONTI, M
    MOLECULAR PHARMACOLOGY, 1995, 48 (04) : 616 - 622